Gabriele Corso

@GabriCorso

Co-founder @Boltz_bio • PhD @MIT • Helping every scientist reshape biology with AI

London, UK gcorso.github.io Joined July 2013

763 Following 11K Followers 2.3K Posts

Latest posts 5

Pinned post

Gabriele Corso @GabriCorso Jun 16

Big news from Boltz - our biggest update yet! 🚀
Today we’re releasing two new state-of-the-art models for protein and small molecule design with extensive wet lab validation and a new API to run all of our models on scalable GPUs wherever you (or your agents) work! 🔥

0:11

Gabriele Corso @GabriCorso Oct 30

Great to see teams using the Boltz API at the Ebolathon successfully designing novel molecules! 140 molecules tested, 11 selective hits in Ebola pseudovirus assays. Exciting to see hackathon ideas turn into experimental results! 🧪 muni.bio/research/hits-…

muni.bio Agents repurposed anti-itch drugs to neutralize the Bundibugyo ebolavirus — muni research An 18.6% hit rate from our Ebola hackathon (Ebolathon). Small molecules that passed the counterscreen selectively inhibited Bundibugyo pseudovirus entry, from de novo designs to a repurposed anti-i...

Gabriele Corso @GabriCorso Oct 21

Today at GTC, we’re excited to announce our collaboration with Bristol Myers Squibb to bring the latest Boltz models into BMS’s drug discovery workflows. @bmsnews @boltz_bio 🚀🧵

0:14

Gabriele Corso @GabriCorso Oct 14

😏

Seb Johnson Verified account @SebJohnsonUK Oct 14

BREAKING: Jensen has just announced that @nvidia in investing $1bn+ into 5 UK startups:

>> Boltz which is building biomolecular models and AI agents that helps scientists predict molecular structures and interactions

>> Foresight which helps owners of major infrastructure projects predict completion dates, mitigate risks and accelerate time to revenue.

>> Hiverge which is building an AI discovery engine that automatically writes and optimizes algorithms for tasks such as faster AI training and complex logistics planning.

>> Prima Mente which focuses on building biological foundation models to decode complex diseases and identify novel therapeutic targets, starting with Alzheimer’s, Parkinson’s and ALS.

>> Riverlane which builds real-time error correction hardware and software that work across all major qubit types, helping quantum computers become reliable enough for practical use.

He announced the news in London this evening.

Apologies for the terrible pic which includes @rowlsmanthorpe’s side profile

View quoted post on X

Gabriele Corso @GabriCorso Oct 14

Boltz on Times Square! Proud to see our team be part of the Disruptors 60 Class of 2026 and to see our work bringing AI-based biomolecular design to every scientist recognized. Thank you to our team, our partners and the scientists building with Boltz!

0:05